Log in to save to my catalogue

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA...

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68761690

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment

About this item

Full title

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment

Publisher

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Journal title

Human mutation, 2006-08, Vol.27 (8), p.748-759

Language

English

Formats

Publication information

Publisher

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

More information

Scope and Contents

Contents

New technology enables expansion of newborn screening (NBS) of inborn errors aimed to prevent adverse outcome. In conditions with a large share of asymptomatic phenotypes, the potential harm created by NBS must carefully be weighed against benefit. Policies vary throughout the United States, Australia, and Europe due to limited data on outcome and...

Alternative Titles

Full title

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68761690

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68761690

Other Identifiers

ISSN

1059-7794

E-ISSN

1098-1004

DOI

10.1002/humu.20349

How to access this item